Find A Portfolio/Ticker
Comparison Box
HQL: H&Q Life Sciences Investors (CEF)
Basic Info 13.38 0.11(0.82%) March 18
Asset Class: | Health |
MyPlanIQ Rating: | (98%) |
Start Date: | 05/01/1992 |
Last Dividend Date: | 02/21/2024 |
12-Mo. Yield | 9.66% |
Expenses | - |
Sign up to get fund ranking change alerts |
Performance Analytics (As of 03/15/2024)
Not up-to-date? TryLast 1 Week* | YTD*(2024) | 1 Yr | 3 Yr | 5 Yr | 10 Yr | 15 Yr | 20 Yr | Since 05/01/1992 |
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annualized Return(%) | -2.6 | 2.2 | 6.9 | -5.0 | 3.6 | 3.7 | 12.7 | 7.9 | 7.1 | 4.2 | -19.2 | 5.5 | 23.7 | 25.5 | -16.2 | 25.4 | -19.5 | 5.8 | 31.3 | 52.1 | 37.3 | 16.4 | 20.3 | 14.8 | -27.8 | 7.3 | -6.7 | 11.9 | 10.9 | 42.1 | -36.0 | 14.5 | 27.4 | 67.5 | -9.0 | -4.5 | -8.3 | 66.7 | -26.5 | -16.2 | -2.5 |
Sharpe Ratio | NA | 0.88 | 0.32 | -0.34 | 0.09 | 0.11 | NA | NA | 0.2 | 0.0 | -0.79 | 0.29 | 0.67 | 1.37 | -0.77 | 1.47 | -0.66 | 0.19 | 1.11 | 2.41 | 2.03 | 0.77 | 1.08 | 0.54 | -0.75 | 0.28 | -0.56 | 0.66 | 0.54 | 2.09 | -1.28 | 0.39 | 0.38 | 2.22 | -0.39 | -0.31 | -0.45 | 2.56 | -1.06 | -0.61 | -0.22 |
Draw Down(%) | NA | 4.9 | 16.2 | 38.9 | 38.9 | 45.2 | NA | NA | 61.7 | 18.5 | 28.7 | 15.1 | 30.5 | 13.9 | 30.1 | 15.8 | 32.7 | 29.9 | 18.5 | 16.7 | 13.8 | 22.9 | 18.2 | 28.7 | 45.6 | 10.7 | 23.0 | 12.9 | 22.8 | 15.1 | 45.3 | 31.0 | 48.6 | 18.8 | 40.2 | 23.5 | 25.9 | 9.9 | 36.3 | 23.5 | 23.8 |
Standard Deviation(%) | NA | 13.8 | 15.5 | 20.2 | 23.4 | 24.8 | NA | NA | 26.9 | 15.7 | 26.2 | 19.0 | 35.0 | 17.6 | 22.6 | 17.0 | 29.9 | 30.8 | 28.2 | 21.6 | 18.5 | 21.1 | 18.8 | 27.2 | 38.0 | 15.6 | 17.9 | 14.7 | 18.6 | 19.8 | 28.9 | 31.6 | 61.6 | 29.0 | 31.5 | 25.5 | 25.9 | 24.5 | 27.9 | 29.7 | 26.9 |
Treynor Ratio | NA | 0.14 | 0.05 | -0.07 | 0.02 | 0.02 | NA | NA | 0.05 | 0.0 | -0.19 | 0.06 | 0.21 | 0.23 | -0.15 | 0.22 | -0.13 | 0.04 | 0.19 | 0.44 | 0.37 | 0.19 | 0.17 | 0.13 | -0.28 | 0.05 | -0.16 | 0.17 | 0.14 | 0.51 | -0.43 | 0.1 | 0.16 | 1.61 | -0.1 | -0.09 | -0.1 | 0.83 | -0.36 | -0.24 | -0.07 |
Alpha | NA | 0.0 | -0.02 | -0.04 | -0.02 | -0.02 | NA | NA | -0.02 | 0.0 | -0.07 | -0.03 | 0.04 | 0.01 | -0.06 | 0.03 | -0.02 | -0.04 | -0.05 | 0.0 | 0.07 | 0.03 | 0.05 | -0.02 | -0.04 | 0.01 | -0.05 | 0.01 | 0.02 | 0.07 | -0.13 | 0.11 | -0.1 | 0.2 | -0.2 | -0.1 | -0.11 | 0.1 | -0.14 | -0.09 | -0.04 |
Beta | NA | 0.89 | 1.02 | 1.05 | 1.08 | 1.2 | NA | NA | 1.07 | 1.01 | 1.11 | 0.97 | 1.12 | 1.03 | 1.2 | 1.11 | 1.46 | 1.46 | 1.66 | 1.19 | 1.03 | 0.87 | 1.16 | 1.14 | 1.04 | 0.93 | 0.61 | 0.56 | 0.7 | 0.81 | 0.86 | 1.27 | 1.43 | 0.4 | 1.3 | 0.89 | 1.23 | 0.76 | 0.81 | 0.77 | 0.87 |
RSquared | NA | 0.5 | 0.57 | 0.58 | 0.68 | 0.62 | NA | NA | 0.36 | 0.57 | 0.72 | 0.33 | 0.79 | 0.62 | 0.7 | 0.42 | 0.62 | 0.65 | 0.58 | 0.33 | 0.31 | 0.55 | 0.63 | 0.59 | 0.61 | 0.42 | 0.1 | 0.11 | 0.15 | 0.33 | 0.36 | 0.38 | 0.2 | 0.04 | 0.43 | 0.21 | 0.2 | 0.05 | 0.08 | 0.1 | 0.12 |
*: NOT annualized;YTD: Year to Date
**Inception: starting from 05/01/1992
Calculate Performance
Start date (MM/dd/yyyy)
End date (MM/dd/yyyy)
View Historical Data in an advanced chart |
Use MyPlanIQ Comparison to compare with multiple funds or portfolios |
See Health Asset Class Trend Rankings |
Top Rated Funds in Health
Best Mutual Funds
- VGHCX (Vanguard Health Care Inv) (97%)
- HGHAX (Hartford Healthcare A) (78%)
- FSMEX (Fidelity Select Medical Equip & Systems) (77%)
- FBIOX (Fidelity Select Biotechnology) (77%)
- FBTIX (Fidelity Advisor Biotechnology I) (77%)
- FSHCX (Fidelity Select Medical Delivery Port) (74%)
- FSPHX (Fidelity Select Health Care) (73%)
- FHCIX (Fidelity Advisor Health Care I) (73%)
- SHSSX (BlackRock Health Sciences Opps Inst) (66%)
- RYOIX (Rydex Biotechnology Inv) (64%)
Best ETFs
- DRGS (RBS Global Big Pharma ETN) (100%)
- XLV (Health Care Select Sector SPDR ETF) (96%)
- BBH (Market Vectors Biotech ETF) (94%)
- IBB (iShares Nasdaq Biotechnology) (94%)
- PPH (Market Vectors Pharmaceutical ETF) (93%)
- FBT (First Trust NYSE Arca Biotech ETF) (91%)
- FXH (First Trust Health Care AlphaDEX ETF) (90%)
- IHE (iShares US Pharmaceuticals) (88%)
- IHF (iShares US Healthcare Providers) (88%)
- IHI (iShares US Medical Devices) (88%)
Best Closed End Funds
- BME (BlackRock Health Sciences) (100%)
- GRX (Gabelli Healthcare & Wellness Trust) (99%)
- HQH (H&Q Healthcare Investors) (98%)
- HQL (H&Q Life Sciences Investors) (98%)